HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Terodiline in the treatment of diurnal enuresis in children.

Abstract
Efficacy and tolerance of the anticholinergic and calcium antagonistic drug terodiline (Mictrol) were investigated in comparison to placebo in 42 children with diurnal enuresis. The study was double-blind with a modified cross-over design with 2 treatment periods of 4 weeks. Terodiline in a daily dose of 25 mg was well tolerated. A statistically significant decrease in the number of wet episodes per day was found with terodiline when compared to placebo. In addition a high patient preference for terodiline was observed. This study shows that terodiline is effective in the treatment of daytime enuresis in children. The low incidence of side-effects also favours the use of terodiline in children.
AuthorsM Elmér, J P Nørgaard, J C Djurhuus, T Adolfsson
JournalScandinavian journal of primary health care (Scand J Prim Health Care) Vol. 6 Issue 2 Pg. 119-24 (May 1988) ISSN: 0281-3432 [Print] United States
PMID3291041 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Butylamines
  • Calcium Channel Blockers
  • terodiline
Topics
  • Adolescent
  • Butylamines (therapeutic use)
  • Calcium Channel Blockers (therapeutic use)
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Double-Blind Method
  • Enuresis (drug therapy)
  • Female
  • Humans
  • Male
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: